A recently completed clinical trial compared GPR183 expression in PBMCs of IBD patients with the CC (minor, imparts IBD risk) and TT (major) alleles of the rs9557195, relevant SNP. This evidence concerns the gene GPR183 and inflammatory bowel disease.